Loading…
Based on limited metadata, Stemell Inc, a biologics manufacturer, received an FDA Warning Letter on August 28, 2019. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning was issued under FDA's biologics regulatory authority, which typically addresses manufacturing, quality control, or compliance issues with biological products. Additional documentation would be needed to identify the specific regulatory violations cited.